Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Wilson H. Roa"'
Autor:
Fan Yang, Deepak Dinakaran, Amr A. Heikal, Shima Yaghoobpour Tari, Sunita Ghosh, John Amanie, Albert Murtha, Lindsay S. Rowe, Wilson H. Roa, Samir Patel
Publikováno v:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 177
There is no consensus on appropriate organ at risk (OAR) constraints for short-course radiotherapy for patients with glioblastoma. Using dosimetry and prospectively-collected toxicity data from a trial of short-course radiotherapy for glioblastoma, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d89f037f38205b895076f7778dbc1f23
https://pubmed.ncbi.nlm.nih.gov/36273738
https://pubmed.ncbi.nlm.nih.gov/36273738
Autor:
Mohammad Mahmoudian, Afshin Namdar, Parvin Zakeri-Milani, Hadi Valizadeh, Shokrollah Elahi, Ahmed M. Darwesh, John M. Seubert, Arno G. Siraki, Wilson H. Roa, Nadia B. Chacra, Raimar Löbenberg
Publikováno v:
Journal of Drug Delivery Science and Technology. 73:103487
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::720fa4a105556cef0e54716350a82741
https://doi.org/10.1016/j.jddst.2022.103487
https://doi.org/10.1016/j.jddst.2022.103487
Autor:
Julian O, Kim, Sayf, Gazala, Rene, Razzak, Linghong, Guo, Sunita, Ghosh, Wilson H, Roa, Eric L R, Bédard
Publikováno v:
Anticancer research. 35(4)
To assess if miRNA expression profiling of bronchoalveolar lavage (BAL) fluid and sputum could be used to detect early-stage non-small cell lung cancer (NSCLC).Hierarchical cluster analysis was performed on the expression levels of 5 miRNAs (miR-21,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e58b3b3578263ed39bf9e4f216709a5b
https://pubmed.ncbi.nlm.nih.gov/25862841
https://pubmed.ncbi.nlm.nih.gov/25862841
Autor:
Jennifer A. Smith, William R. Shapiro, Miller Richard A, Judith Ford, Wilson H. Roa, Christina A. Meyers, Mark H. Leibenhaut, Michael Glantz, Christopher J. Schultz, Minesh P. Mehta, Roy A. Patchell, Walter J. Curran, Markus F. Renschler, See Phan, Michael A. Weitzner
Publikováno v:
Journal of Clinical Oncology. 20:3445-3453
PURPOSE: Motexafin gadolinium is a redox mediator that selectively targets tumor cells, is detectable by magnetic resonance imaging (MRI), and enhances the effect of radiation therapy. This lead-in phase to a randomized trial served to evaluate radio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::356d1982804ce8698f5b032863fa7c53
https://doi.org/10.1200/jco.2002.07.500
https://doi.org/10.1200/jco.2002.07.500
Autor:
Wilson H, Roa, Hua, Chen, Dorcas, Fulton, Sunil, Gulavita, Andrew, Shaw, John, Th'ng, Maxine, Farr-Jones, Ronald, Moore, Kenneth, Petruk
Publikováno v:
Clinical and investigative medicine. Medecine clinique et experimentale. 26(5)
The X-chromosome-linked inhibitor of apoptosis protein (XIAP) prevents apoptosis from activated transmembrane death receptors and confers tumour resistance to irradiation and chemotherapy. Despite the important oncologic implications, data concerning
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f9ef6fd26caade629156254fd419acaf
https://pubmed.ncbi.nlm.nih.gov/14596484
https://pubmed.ncbi.nlm.nih.gov/14596484
Autor:
Shannon S Yoo, Linghong Guo, Xuejun Sun, Andrew R Shaw, Zhipeng Yuan, Raimar Löbenberg, Wilson H Roa
Publikováno v:
Nanotechnology; 9/23/2016, Vol. 27 Issue 38, p1-1, 1p
Autor:
Shannon S Yoo, Rene Razzak, Eric Bédard, Linghong Guo, Andrew R Shaw, Ronald B Moore, Wilson H Roa
Publikováno v:
Nanotechnology; 10/24/2014, Vol. 25 Issue 42, p1-1, 1p